Improved endothelial function with simvastatin but unchanged insulin sensitivity with simvastatin or ezetimibe
- 30 June 2010
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 59 (6) , 921-926
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Simvastatin (40 mg/day), Adiponectin Levels, and Insulin Sensitivity in Subjects With the Metabolic SyndromeThe American Journal of Cardiology, 2007
- Reciprocal relationships between abnormal metabolic parameters and endothelial dysfunctionCurrent Opinion in Lipidology, 2007
- Direct Demonstration of an Antiinflammatory Effect of Simvastatin in Subjects with the Metabolic SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2006
- Effects of amlodipine-atorvastatin combination on inflammation markers and insulin sensitivity in normocholesterolemic obese hypertensive patientsEuropean Journal of Clinical Pharmacology, 2006
- Effect of Atorvastatin (10 mg/day) on Glucose Metabolism in Patients With the Metabolic SyndromeThe American Journal of Cardiology, 2006
- Effect of Pravastatin and Atorvastatin on Glucose Metabolism in NonDiabetic Patients with HypercholesterolemiaInternal Medicine, 2006
- Endothelial inflammation in insulin resistanceThe Lancet, 2005
- Pravastatin Improves Insulin Resistance in Dyslipidemic PatientsJournal of Atherosclerosis and Thrombosis, 2005
- Chronic Subclinical Inflammation as Part of the Insulin Resistance SyndromeCirculation, 2000
- Effects of simvastatin and atorvastatin administration on insulin resistance and respiratory quotient in aged dyslipidemic non-insulin dependent diabetic patientsAtherosclerosis, 2000